SHEILA WOLFRUM: Open Payments
NPI 1194355982 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,472 in 89 payments from 14 companies in 2025. Trend: 2023 $1,271 · 2024 $1,228 · 2025 $1,472
Food & beverage: $1,472
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $306 |
| Otsuka America Pharmaceutical, Inc. | 11 | $189 |
| Lundbeck LLC | 15 | $173 |
| ABBVIE INC. | 8 | $143 |
| Alkermes, Inc. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Tris Pharma Inc | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
Products named: REXULTI, COBENFY, VRAYLAR, ARISTADA, CAPLYTA, Dyanavel XR, Qelbree, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
